← Stock Trading Canary · All insider profiles
INSIDER PROFILE · SE
Joakim Tedroff
Annan medlem i bolagets administrations-, lednings- eller kontrollorgan
Profile key: se|joakim tedroff
Purchase history
- Companies traded
- 1
- Purchases · 12M
- 5
- Purchases · 24M
- 7
- Average purchase
- SEK 1,129,204
- Gross purchase value
- SEK 7,904,431
- Last purchase
- 2026-07-01
- Completed 20D events
- 7.0
- Outcome status
- PASS
Latest company: IRLAB Therapeutics AB
Companies: IRLAB Therapeutics AB
Post-purchase outcomes
Benchmark-relative outcomes are available against OMX Stockholm 30.
- Excess return = stock return − OMX Stockholm 30 return over the same period.
- Hit rate = positive excess-return events ÷ completed events.
- Price coverage = valid point-in-time prices ÷ events mature enough for that period.
- Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 7Developing | 100.0% (7/7) | 42.9% (3/7) | -0.8% | +0.6% | -11.6% |
| 20D | 7Developing | 100.0% (7/7) | 28.6% (2/7) | -10.5% | -7.8% | -17.0% |
| 60D | 7Developing | 100.0% (7/7) | 28.6% (2/7) | -29.2% | -11.6% | -40.8% |
| 120D | 5Developing | 100.0% (5/5) | 0.0% (0/5) | -56.3% | -56.5% | -59.4% |
Research patterns
- First purchase in 12M
- 2/6
- Large purchase ≥ €100k
- 2/7
- Cluster buying · 15D
- 2/7
- Buying the dip · ≥20% below prior 52W high
- 7/7
- Routine / opportunistic
- Not classifiable
Counts are profile-wide, point-in-time research labels. They never affect the insider score or ranking.
Every completed outcome is shown; n<5 is descriptive small-sample evidence and is not scored. Disclosure-level observations published on the same date may share a return path and may not be statistically independent. These results never affect the insider score or ranking.